Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
Non-viral, polymeric-based, siRNA nanoparticles (NPs) have been proposed as promising gene delivery systems. Encapsulating siRNA in targeted NPs could confer improved biological stability, extended half-life, enhanced permeability, effective tumor accumulation, and therapy. In this work, a peptide d...
Main Authors: | Meital Ben-David-Naim, Arie Dagan, Etty Grad, Gil Aizik, Mirjam M. Nordling-David, Alisa Morss Clyne, Zvi Granot, Gershon Golomb |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/442 |
Similar Items
-
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
by: Wanyi Tai
Published: (2019-06-01) -
Functional analysis of tumor metastasis: modeling colon cancer
by: Philip Y. Wai, et al.
Published: (2011-12-01) -
Functional analysis of tumor metastasis: modeling colon cancer
by: Philip Y. Wai, et al.
Published: (2011-12-01) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012-01-01) -
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
by: Socheata Ly, et al.
Published: (2020-09-01)